Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T61052
(Former ID: TTDI01289)
|
|||||
Target Name |
Neuroepithelial receptor (NR)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Female pelvic pain [ICD-11: GA34] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | PH-80 | Drug Info | Phase 3 | Premenstrual syndrome | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | PH-80 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Patents by Assignee Pherin Corporation. | |||||
REF 2 | ClinicalTrials.gov (NCT01217775) Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.